Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Health awareness among young women vaccinated against human papillomavirus infections
 
More details
Hide details
 
Submission date: 2013-11-13
 
 
Final revision date: 2014-03-06
 
 
Acceptance date: 2014-03-06
 
 
Publication date: 2014-04-01
 
 
Medical Studies 2014;30(1):21-26
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Genital human papillomavirus (HPV) infections are essentials factors in the development of cervical cancer. Human papillomavirus vaccines can contribute to reducing the high incidence of this disease, provided that this form of prophylaxis is commonly accepted. Participation in vaccinations is restricted by the belief that their implementation and consequent feeling of safety will reduce women’s participation in other forms of cervical carcinoma prophylaxis and will encourage them to be sexually promiscuous.
Aim of the research study: To determine the awareness of cervical carcinoma prophylaxis among young women vaccinated against HPV by comparing them with a group of unvaccinated women.
Material and methods: The survey covered a group of 210 young women in the age range 18 to 20 years, who were vaccinated against HPV. Within the framework of comparison, the survey covered a group of 255 young HPV-unvaccinated women, adequately selected in respect of age and education.
Results: The HPVvaccinated women declared participation in medical check-ups and cytological tests no less frequently than the unvaccinated women. In both groups, the usage of condoms, sexual partners hygiene, monogamy and smoking abstinence were determined as behaviours limiting the occurrence of cervical carcinoma.
Conclusions: Awareness of the application of supplementary prophylaxis of cervical carcinoma was high among the HPV vaccinated woman and did not differ from the unvaccinated woman’s awareness. Young women did not show a tendency for promiscuous behaviours, and were more likely touse condoms in the prevention of cervical carcinoma than were the unvaccinated woman.
REFERENCES (21)
1.

Krajowy Rejestr Nowotworów. Centrum Onkologii – Instytut M. Skłodowskiej-Curie. Zakład Epidemiologii Nowotworów, http.//epid.coi.waw.pl./krn/, 2011.10.10.
 
2.

Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297: 813-819.
 
3.

Bosch FX, Lorincz A, Munoz N, et al. The casual relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
 
4.

Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use and risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 82: 1332-1338.
 
5.

Castellsague X, de Sanjose S, Aguado T, et al. HPV and cervical cancer in the world 2007 report. Vaccine 2007; 25: 1-26.
 
6.

Castellsague X. Natura history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008; 110.
 
7.
(3 Suppl 2): S4-S7.
 
8.

Majewski S, Wysocki J, Sikorski M, et al.; Polish Society of HPV Infections Prophylaxis. Recommendations of the Polish Society of HPV Infections Prophylaxis – (PS-HPVIP) (Polskie towarzystwo profilaktyki zakażeń HPV – PTPZ HPV) concerning the use of preventive vaccines against HPV. Med Wieku Rozwoj 2008; 12: 621-625, 627-631.
 
9.

Udesky L. Push to mandate HPV vaccine triggers backlash in USA. Lancet 2007; 369: 979-980.
 
10.

Ogilvie G, Anderson M, Marra F, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010; 7: e1000270.; http://www.ncbi.nlm.nih.gov/pu..., pobrano 2012.01.01.
 
11.

Ferris D, Horn L, Waller JL. Parental acceptance of a mandatory human papillomavirus (HPV) vaccination program. J Am Board Fam Med 2010; 23: 220-229.
 
12.

Izdebski Z. Seksualność Polaków na początku XXI wieku. Wydawnictwo Uniwersytetu Jagiellońskiego, Krakow 2012.
 
13.

Bernard DM, Cooper Robbins SC, McCaffery KJ, et al. The domino effect: adolescent girls’ response to human papillomavirus vaccination. Med J Aust 2011; 194: 297-300.
 
14.

Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004; 96: 604-615.
 
15.

Torvinen S, Nieminen P, Lehtinen M. Cost effectiveness of prophylactic HPV 16/18 vaccination in Finland: results from a modelling exercise. J Med Econ 2010; 13: 284-294.
 
16.

Spaczyński M, Malkowska-Walczak E, Nowak-Markwitz E, et al. Rola badania cytologicznego i testu DNA HPV w dobie szczepionki antywirusowej. In: Rak szyjki macicy. Profilaktyka, diagnostyka i leczenie. Spaczyński M, Kędzia W, Nowak-Markwitz E (eds.). Wydawnictwo Lekarskie PZWL, Warsaw 2009; 95-105.
 
17.

Franco EL, Cuzick J, Hildesheim A, et al. Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 2006; 24 (Suppl. 3): S171-S177.
 
18.

Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29: 725-735.
 
19.

Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003; 107: 811-816.
 
20.

Bretas JR, Ohara CV, Jardim DP, et al. Aspects of sexuality in adolescence. Cien Saude Colet 2011; 16: 3221-3228.
 
21.

Tyden T, Palmqvist M, Larsson M. A repeated survey of sexual behavior among female university students in Sweden. Acta Obstet Gynecol Scand 2012; 91: 215-219.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top